Citations (57)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Eliska Dvorackova, Martin Sima, Kristyna Vyskocilova, Tereza Kotowski, Kateřina Dunovská, Eva Klapkova, Jan Havlin, Robert Lischke & Ondrej Slanar. (2023) Population pharmacokinetics and covariate-based dosing individualization of voriconazole in lung transplant recipients. Journal of Chemotherapy 0:0, pages 1-10.
Read now
Read now
Josefine Schulz, Franziska Kluwe, Gerd Mikus, Robin Michelet & Charlotte Kloft. (2019) Novel insights into the complex pharmacokinetics of voriconazole: a review of its metabolism. Drug Metabolism Reviews 51:3, pages 247-265.
Read now
Read now
Gulsum Iclal Bayhan, Mesut Garipardic, Kamuran Karaman & Sinan Akbayram. (2016) Voriconazole-associated visual disturbances and hallucinations. Cutaneous and Ocular Toxicology 35:1, pages 80-82.
Read now
Read now
Hemant Malhotra, Pratibha Sharma, Shipra Bhargava, Om Singh Rathore, Bharti Malhotra & Madhu Kumar. (2014) Correlation of plasma trough levels of imatinib with molecular response in patients with chronic myeloid leukemia. Leukemia & Lymphoma 55:11, pages 2614-2619.
Read now
Read now
Yeon-Joo Lee, Sang-Oh Lee, Sang-Ho Choi, Yang Soo Kim, Jun Hee Woo, Sail Chun, Dae-Young Kim, Jung-Hee Lee, Je-Hwan Lee, Kyoo-Hyung Lee & Sung-Han Kim. (2013) Initial voriconazole trough blood levels and clinical outcomes of invasive aspergillosis in patients with hematologic malignancies. Medical Mycology 51:3, pages 324-330.
Read now
Read now
Articles from other publishers (52)
Johan A. Maertens, Galia Rahav, Dong-Gun Lee, Shariq Haider, Isabel Cristina Ramirez-Sanchez, Nikolai Klimko, Alfredo Ponce-de-León, Seongah Han, Rebecca Wrishko, Gregory A. Winchell, Anjana Grandhi & Hetty Waskin. (2023) Pharmacokinetic and Exposure Response Analysis of the Double-Blind Randomized Study of Posaconazole and Voriconazole for Treatment of Invasive Aspergillosis. Clinical Drug Investigation.
Crossref
Crossref
Mehwish Mushtaq, Kshaf Fatima, Aneeqa Ahmad, Osama Mohamed Ibrahim, Muhammad Faheem & Yasar Shah. (2023) Pharmacokinetic interaction of voriconazole and clarithromycin in Pakistani healthy male volunteers: a single dose, randomized, crossover, open-label study. Frontiers in Pharmacology 14.
Crossref
Crossref
Laís de Almeida Campos, Margani Taise Fin, Kelvin Sousa Santos, Marcos William de Lima Gualque, Ana Karla Lima Freire Cabral, Najeh Maissar Khalil, Ana Marisa Fusco-Almeida, Rubiana Mara Mainardes & Maria José Soares Mendes-Giannini. (2023) Nanotechnology-Based Approaches for Voriconazole Delivery Applied to Invasive Fungal Infections. Pharmaceutics 15:1, pages 266.
Crossref
Crossref
Nhi Nguyen, Hubert C. Chua, Ty Drake, Jinhee Jo, Stefanie Anne Stramel, Nancy N. Vuong, Anne J. Gonzales-Luna, Kelsey Olson & on behalf of the Houston Infectious Diseases Network. (2022) Significant Publications on Infectious Diseases Pharmacotherapy in 2021. Journal of Pharmacy Practice, pages 089719002211283.
Crossref
Crossref
Juan Chen, Ying Wu, Yuelin He, Xiaoqin Feng, Yuqiong Ren & Shiting Liu. (2022) Combined Effect of CYP2C19 Genetic Polymorphisms and C-Reactive Protein on Voriconazole Exposure and Dosing in Immunocompromised Children. Frontiers in Pediatrics 10.
Crossref
Crossref
Josefine Schulz, Antonia Thomas, Ayatallah Saleh, Gerd Mikus, Charlotte Kloft & Robin Michelet. (2022) Towards the Elucidation of the Pharmacokinetics of Voriconazole: A Quantitative Characterization of Its Metabolism. Pharmaceutics 14:3, pages 477.
Crossref
Crossref
Yaser Mohammed, Ahmed Abousamra, Ahmed Atef I Abdeldayem, Mansoor Zafar & Tila Muhammad. (2022) Voriconazole-Induced Cholestatic Hepatotoxicity in an Immune Competent Patient. Cureus.
Crossref
Crossref
Azka Yaqoob, Qudsia Rehman, Kanwal Rehman, Muhammad Sajid Hamid Akash, Iqbal Hussain & Rasheed Ahmad. 2022. Biochemistry of Drug Metabolizing Enzymes. Biochemistry of Drug Metabolizing Enzymes
73
108
.
Daniela Vrinceanu, Mihai Dumitru, Oana Patrascu, Adrian Costache, Toma Papacocea & Romica Cergan. (2021) Current diagnosis and treatment of rhinosinusal aspergilloma (Review). Experimental and Therapeutic Medicine 22:5.
Crossref
Crossref
José María Valle-T-Figueras, Berta Renedo Miró, Maria Isabel Benítez Carabante, Cristina Díaz-de-Heredia, Jaume Vima Bofarull, Natalia Mendoza-Palomar, Maria Teresa Martín-Gómez & Pere Soler-Palacín. (2021) Voriconazole Use in Children: Therapeutic Drug Monitoring and Control of Inflammation as Key Points for Optimal Treatment. Journal of Fungi 7:6, pages 456.
Crossref
Crossref
Johan A Maertens, Galia Rahav, Dong-Gun Lee, Alfredo Ponce-de-León, Isabel Cristina Ramírez Sánchez, Nikolay Klimko, Anne Sonet, Shariq Haider, Juan Diego Vélez, Issam Raad, Liang-Piu Koh, Meinolf Karthaus, Jianying Zhou, Ronen Ben-Ami, Mary R Motyl, Seongah Han, Anjana Grandhi & Hetty Waskin. (2021) Posaconazole versus voriconazole for primary treatment of invasive aspergillosis: a phase 3, randomised, controlled, non-inferiority trial. The Lancet 397:10273, pages 499-509.
Crossref
Crossref
Stephanie Duehlmeyer, Christopher Klockau, Diana Yu & Jamie Rouch. (2021) Characterization of Therapeutic Drug Monitoring Practices of Voriconazole and Posaconazole at a Pediatric Hospital. The Journal of Pediatric Pharmacology and Therapeutics 26:1, pages 26-32.
Crossref
Crossref
Shin-Lun Wu, Chih-Ning Cheng, Chi-Chuan Wang, Shu-Wen Lin & Ching-Hua Kuo. (2020) Metabolomics analysis of plasma reveals voriconazole-induced hepatotoxicity is associated with oxidative stress. Toxicology and Applied Pharmacology 403, pages 115157.
Crossref
Crossref
Markus Ruhnke, Oliver A. Cornely, Martin Schmidt‐Hieber, Nael Alakel, Boris Boell, Dieter Buchheidt, Maximilian Christopeit, Justin Hasenkamp, Werner J. Heinz, Marcus Hentrich, Meinolf Karthaus, Michael Koldehoff, Georg Maschmeyer, Jens Panse, Olaf Penack, Jan Schleicher, Daniel Teschner, Andrew John Ullmann, Maria Vehreschild, Marie von Lilienfeld‐Toal, Florian Weissinger & Stefan Schwartz. (2020) Treatment of invasive fungal diseases in cancer patients—Revised 2019 Recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Mycoses 63:7, pages 653-682.
Crossref
Crossref
Sarah Allegra, Silvia De Francia, Amedeo De Nicolò, Jessica Cusato, Valeria Avataneo, Alessandra Manca, Miriam Antonucci & Antonio D’Avolio. (2020) Effect of Gender and Age on Voriconazole Trough Concentrations in Italian Adult Patients. European Journal of Drug Metabolism and Pharmacokinetics 45:3, pages 405-412.
Crossref
Crossref
Qi Huang, Qiong Liu, Tao Yin, Lin Hu, Hanjun Ding, Shao Liu & Yueping Jiang. (2020) Effect of proton pump inhibitors on voriconazole concentrations in Chinese patients with malignant hematological diseases. European Journal of Clinical Pharmacology 76:6, pages 833-842.
Crossref
Crossref
Zainab Bandalizadeh, Tahereh Shokohi, Hamid Badali, Mahdi Abastabar, Farhang Babamahmoudi, Lotfolah Davoodi, Masoud Mardani, Mostafa Javanian, Hamed Cheraghmakani, Ali Asghar Sepidgar, Parisa Badiee, Sadegh Khodavaisy, Setareh Agha Kuchak Afshari, Kazem Ahmadikia & Seyedmojtaba Seyedmousavi. (2020) Molecular epidemiology and antifungal susceptibility profiles of clinical Cryptococcus neoformans/Cryptococcus gattii species complex. Journal of Medical Microbiology 69:1, pages 72-81.
Crossref
Crossref
Lin Cheng, Rongfeng Xiang, Fang Liu, Yuliang Li, Heli Chen, Pu Yao, Fengjun Sun & Peiyuan Xia. (2020) Therapeutic drug monitoring and safety of voriconazole in elderly patients. International Immunopharmacology 78, pages 106078.
Crossref
Crossref
Syed Haris Tasleem & Mitchell S. Cappell. (2019) Voriconazole-Induced Hepatotoxicity Presenting With Severe Hepatic Encephalopathy After Liver Transplantation. ACG Case Reports Journal 6:3, pages e00010.
Crossref
Crossref
Dan Tang, Bai‐Li Song, Miao Yan, Jian‐Jun Zou, Min Zhang, Hua‐Ying Zhou, Feng Wang, Yi‐Wen Xiao, Ping Xu, Bi‐Kui Zhang, Xi‐Jing Chen, Da‐Xiong Xiang & Hoan Linh Banh. (2019) Identifying factors affecting the pharmacokinetics of voriconazole in patients with liver dysfunction: a population pharmacokinetic approach. Basic & Clinical Pharmacology & Toxicology.
Crossref
Crossref
Nikolaos Spernovasilis & Diamantis Kofteridis. (2018) Pre-Existing Liver Disease and Toxicity of Antifungals. Journal of Fungi 4:4, pages 133.
Crossref
Crossref
Galina I. Lepesheva, Laura Friggeri & Michael R. Waterman. (2018) CYP51 as drug targets for fungi and protozoan parasites: past, present and future. Parasitology 145:14, pages 1820-1836.
Crossref
Crossref
Ignacio G. Bressán, Mariana L. Mendez & María I. Gimenez. (2018) Validation of a Reversed-Phase Ultra–High-Performance Liquid Chromatographic Method With Photodiode Array Detection for the Determination of Voriconazole in Human Serum and Its Application to Therapeutic Drug Monitoring. Therapeutic Drug Monitoring 40:2, pages 276-283.
Crossref
Crossref
Zahra Hashemizadeh, Parisa Badiee, Seyed Ali Malekhoseini, Hadi Raeisi Shahraki, Bita Geramizadeh & Hashem Montaseri. (2017) Observational Study of Associations between Voriconazole Therapeutic Drug Monitoring, Toxicity, and Outcome in Liver Transplant Patients. Antimicrobial Agents and Chemotherapy 61:12.
Crossref
Crossref
Xiaoyan Liu, Haibin Su, Jingjing Tong, Jing Chen, Haozhen Yang, Long Xiao, Jinhua Hu & Lina zhang. (2017) Significance of monitoring plasma concentration of voriconazole in a patient with liver failure. Medicine 96:42, pages e8039.
Crossref
Crossref
Omar Abdulhameed Almazroo, Mohammad Kowser Miah & Raman Venkataramanan. (2017) Drug Metabolism in the Liver. Clinics in Liver Disease 21:1, pages 1-20.
Crossref
Crossref
M. A. Encalada Ventura, M. J. P. van Wanrooy, L. F. R. Span, M. G. G. Rodgers, E. R. van den Heuvel, D. R. A. Uges, T. S. van der Werf, J. G. W. Kosterink & J. W. C. Alffenaar. (2016) Longitudinal Analysis of the Effect of Inflammation on Voriconazole Trough Concentrations. Antimicrobial Agents and Chemotherapy 60:5, pages 2727-2731.
Crossref
Crossref
Prerna K. Chawla, Alpa J. Dherai & Tester F. Ashavaid. (2015) Plasma Voriconazole Estimation by HPLC. Indian Journal of Clinical Biochemistry 31:2, pages 209-214.
Crossref
Crossref
P. K. Shukla, Pratiksha Singh, Ravindra Kumar Yadav, Smriti Pandey & Shome S. Bhunia. 2018. Communicable Diseases of the Developing World. Communicable Diseases of the Developing World
125
167
.
Maricela Valerio, Antonio Vena, Emilio Bouza, Nanna Reiter, Pierluigi Viale, Marcel Hochreiter, Maddalena Giannella & Patricia Muñoz. (2015) How much European prescribing physicians know about invasive fungal infections management?. BMC Infectious Diseases 15:1.
Crossref
Crossref
Prerna K. Chawla, Shweta R. Nanday, Alpa J. Dherai, Rajeev Soman, Rohan V. Lokhande, Prasad R. Naik & Tester F. Ashavaid. (2015) Correlation of CYP2C19 genotype with plasma voriconazole levels: a preliminary retrospective study in Indians. International Journal of Clinical Pharmacy 37:5, pages 925-930.
Crossref
Crossref
H.R. Ashbee & M.H. Gilleece. 2014. Handbook of Pharmacogenomics and Stratified Medicine. Handbook of Pharmacogenomics and Stratified Medicine
879
900
.
Stefania-Felicia Barbuceanu, Gabriela Bancescu, Gabriel Saramet, Florica Barbuceanu, Constantin Draghici, Flavian Stefan Radulescu, Aura Ionescu & Simona Negres. (2013)
Synthesis and Biological Evaluation of Some New
N
1
-[4-(4-Chlorophenylsulfonyl)benzoyl]-
N
?4
-(aryl)-thiosemicarbazides and Products of Their Cyclization
. Heteroatom Chemistry 24:4, pages 309-321.
Crossref
Crossref
Spinello Antinori, Mario Corbellino, Luca Meroni, Federico Resta, Salvatore Sollima, Massimo Tonolini, Anna Maria Tortorano, Laura Milazzo, Lorenzo Bello, Elisa Furfaro, Massimo Galli & Claudio Viscoli. (2013) Aspergillus meningitis: A rare clinical manifestation of central nervous system aspergillosis. Case report and review of 92 cases. Journal of Infection 66:3, pages 218-238.
Crossref
Crossref
Daniela Silva Granzoto, Lúcia Helena Vitali & Roberto Martinez. (2013) Efficacy of voriconazole in experimental rat paracoccidioidomycosis. Revista da Sociedade Brasileira de Medicina Tropical 46:1, pages 79-83.
Crossref
Crossref
Si-Hyun KimDong-Gun LeeJae-Cheol KwonHyo-Jin LeeSung-Yeon ChoChulmin ParkEun-Young KwonSun Hee ParkSu-Mi ChoiJung-Hyun ChoiJin-Hong Yoo. (2013) Clinical Impact of Cytochrome P450 2C19 Genotype on the Treatment of Invasive Aspergillosis under Routine Therapeutic Drug Monitoring of Voriconazole in a Korean Population. Infection & Chemotherapy 45:4, pages 406.
Crossref
Crossref
Thomas N. Kakuda, Rodica Van Solingen‐Ristea, Fatima Aharchi, Goedele De Smedt, James Witek, Steven Nijs, Veerle Vyncke & Richard M. W. Hoetelmans. (2013) Pharmacokinetics and Short‐Term Safety of Etravirine in Combination With Fluconazole or Voriconazole in HIV‐Negative Volunteers. The Journal of Clinical Pharmacology 53:1, pages 41-50.
Crossref
Crossref
Imke H. Bartelink, Tom Wolfs, Martine Jonker, Marjolein de Waal, Toine C. G. Egberts, Tessa T. Ververs, Jaap J. Boelens & Marc Bierings. (2013) Highly Variable Plasma Concentrations of Voriconazole in Pediatric Hematopoietic Stem Cell Transplantation Patients. Antimicrobial Agents and Chemotherapy 57:1, pages 235-240.
Crossref
Crossref
Shobini Sivagnanam, Sharon C.-A. Chen, Catriona Halliday & Donald Packham. (2013) Thermomyces lanuginosus infective endocarditis: Case report and a review of endocarditis due to uncommon moulds. Medical Mycology Case Reports 2, pages 152-155.
Crossref
Crossref
Ren-ai Xu, Shuang-li Zheng, Li-li Xiao, Xue-ding Cai, Xi-xi Lai, Guan-yang Lin, Lu-feng Hu, Chun-hong Zhang, Zhi-sheng Xu & Xiu-hua Zhang. (2013) Therapeutic drug monitoring in voriconazole-associated hyponatremia. Medical Mycology Case Reports 2, pages 134-136.
Crossref
Crossref
H. Hof & G. Mikus. (2012) Candida-Infektionen im hohen AlterCandida infections in the elderly. Zeitschrift für Gerontologie und Geriatrie 46:1, pages 64-70.
Crossref
Crossref
Soo‐Han Choi, Soo‐Youn Lee, Ji‐Young Hwang, Soo Hyun Lee, Keon Hee Yoo, Ki Woong Sung, Hong Hoe Koo & Yae‐Jean Kim. (2012) Importance of voriconazole therapeutic drug monitoring in pediatric cancer patients with invasive aspergillosis. Pediatric Blood & Cancer 60:1, pages 82-87.
Crossref
Crossref
Werner J. Heinz & Hartwig Klinker. (2012) Therapeutic drug monitoring of antifungal agents. Laboratoriumsmedizin 36:2, pages 1-10.
Crossref
Crossref
P. Soler-Palacin, M. A. Frick, A. Martin-Nalda, M. Lanaspa, L. Pou, E. Rosello, C. Diaz de Heredia & C. Figueras. (2011) Voriconazole drug monitoring in the management of invasive fungal infection in immunocompromised children: a prospective study. Journal of Antimicrobial Chemotherapy 67:3, pages 700-706.
Crossref
Crossref
Jennifer Chen, Carol Chan, David Colantonio & Winnie Seto. (2012) Therapeutic Drug Monitoring of Voriconazole in Children. Therapeutic Drug Monitoring 34:1, pages 77-84.
Crossref
Crossref
Werner J. Heinz & Hartwig Klinker. (2012) Therapeutisches Drug Monitoring von Antimykotika/Therapeutic drug monitoring of antifungal agents. LaboratoriumsMedizin 36:2.
Crossref
Crossref
Emilia Mellado, Laura Alcazar-Fuoli, Manuel Cuenca-Estrella & Juan L. Rodriguez-Tudela. (2011) Role of Aspergillus lentulus 14-α Sterol Demethylase (Cyp51A) in Azole Drug Susceptibility. Antimicrobial Agents and Chemotherapy 55:12, pages 5459-5468.
Crossref
Crossref
Si-Hyun Kim, Dong-Seok Yim, Su-Mi Choi, Jae-Cheol Kwon, Seunghoon Han, Dong-Gun Lee, Chulmin Park, Eun-Young Kwon, Sun Hee Park, Jung-Hyun Choi & Jin-Hong Yoo. (2011) Voriconazole-related severe adverse events: clinical application of therapeutic drug monitoring in Korean patients. International Journal of Infectious Diseases 15:11, pages e753-e758.
Crossref
Crossref
E. Gaïes, N. Jebabli, I. Salouage, S. Trabelsi, R. Charfi, M. Lakhal & A. Klouz. (2011) Hallucinations auditives induites par le voriconazole : illustration par le monitorage plasmatique. Journal de Mycologie Médicale 21:3, pages 214-216.
Crossref
Crossref
Darlize H?bner Martins, Sandrine Comparsi Wagner, Tamyris Vianna dos Santos, Lilian de Lima Feltraco Lizot, Marina Venzon Antunes, Marcelo Capra & Rafael Linden. (2011) Monitoring imatinib plasma concentrations in chronic myeloid leukemia. Revista Brasileira de Hematologia e Hemoterapia 33:4, pages 302-306.
Crossref
Crossref
Min-Ju KimMoon-Hee YounSang-Bae KimYul Hee ChoMin-Young LeeSung-Yeon ChoJae-Cheol KwonSi-Hyun KimYoo-Jin KimDong-Gun Lee. (2011) A Case of Visual and Auditory Hallucinations during Intravenous Voriconazole Therapy. Infection and Chemotherapy 43:5, pages 421.
Crossref
Crossref
Michael J. Dolton & Andrew J. McLachlan. (2011) Clinical importance of the CYP2C19*17 variant allele for voriconazole. British Journal of Clinical Pharmacology 71:1, pages 137-138.
Crossref
Crossref